UK markets close in 2 hours 46 minutes

NeuroOne Medical Technologies Corporation (NMTC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8685-0.0516 (-5.61%)
At close: 04:00PM EDT
0.8382 -0.03 (-3.49%)
Pre-market: 08:42AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Cash flows from operating activities
Net income
-12,804
-11,859
-10,000
-9,948
-13,640
-
Depreciation & amortisation
239.024
199.266
118.62
80.748
47.609
-
Stock-based compensation
1,233
1,105
947.212
1,793
1,836
-
Change in working capital
-637.779
-2,429
1,214
-512.733
-429.563
-
Accounts receivable
-341.687
33.237
15.099
-48.336
0
-
Inventory
-137.366
-1,022
-606.251
-98.287
0
-
Accounts payable
-145.428
-247.189
515.438
-350.313
-269.601
-
Other working capital
-12,093
-13,271
-7,795
-8,670
-3,548
-
Other non-cash items
114.281
109.832
212.155
69.435
6,743
-
Net cash provided by operating activities
-11,828
-12,887
-7,520
-8,603
-3,425
-
Cash flows from investing activities
Investments in property, plant and equipment
-265.402
-384.117
-275.226
-67.079
-122.427
-
Purchases of investments
0
-1,473
-3,470
0
-
-
Sales/maturities of investments
1,000
4,500
500
0
-
-
Net cash used for investing activities
742.098
2,650
-3,245
-67.079
-122.427
-
Cash flows from financing activities
Debt repayment
-
-
-
-
0
-283
Common stock issued
11,012
8,590
13,351
8,829
390
-
Common stock repurchased
-45.623
-119.419
0
-
-
-
Other financing activities
-1,049
-1,072
-1,327
-1,250
-1,510
-
Net cash used provided by (used for) financing activities
9,918
7,399
12,023
11,535
7,323
-
Net change in cash
-1,168
-2,838
1,259
2,865
3,776
-
Cash at beginning of period
3,602
8,160
6,901
4,036
260.749
-
Cash at end of period
2,435
5,322
8,160
6,901
4,036
-
Free cash flow
Operating cash flow
-11,828
-12,887
-7,520
-8,603
-3,425
-
Capital expenditure
-265.402
-384.117
-275.226
-67.079
-122.427
-
Free cash flow
-12,093
-13,271
-7,795
-8,670
-3,548
-